Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: A prospective cross-sectional study

BMC Oral Health

Volumn 15, Issue 1, 2015, Pages

  Ata Ali, Javier ^a,b   Flichy Fernández, Antonio Juan ^b   Alegre Domingo, Teresa ^b   Ata Ali, Fadi ^b   Palacio, Jose ^c   Peñarrocha Diago, Miguel ^b  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cytokine; Dental implant; Peri implant diseases; Peri implant sulcus fluid (PISF); Peri implantitis; Periodontal pathogens; Review

Indexed keywords

IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TOOTH IMPLANT; TUMOR NECROSIS FACTOR;

AGED; ANATOMY AND HISTOLOGY; BACTERIAL LOAD; BACTEROIDES; CHEMISTRY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PERIIMPLANTITIS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; PLAQUE INDEX; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDY; TOOTH ARCH; TOOTH IMPLANT; TOOTH PROSTHESIS; TREPONEMA DENTICOLA;

AGED; BACTERIAL LOAD; BACTEROIDES; CROSS-SECTIONAL STUDIES; DENTAL ARCH; DENTAL IMPLANTS; DENTAL PLAQUE INDEX; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PERI-IMPLANTITIS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDIES; TREPONEMA DENTICOLA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926628272     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/s12903-015-0031-9     Document Type: Article

References (69)

1. Charalampakis G, Leonhardt Å, Rabe P, Dahlén G. Clinical and microbiological characteristics of peri-implantitis cases: a retrospective multicentre study. Clin Oral Implants Res. 2012;23:1045-54.
2. Lekholm U, Gröndahl K, Jemt T. Outcome of oral implant treatment in partially edentulous jaws followed 20 years in clinical function. Clin Implant Dent Relat Res. 2006;8:178-86.
3. Astrand P, Ahlqvist J, Gunne J, Nilson H. Implant treatment of patients with edentulous jaws: a 20-year follow-up. Clin Implant Dent Relat Res. 2008;10:207-17.
4. Kim TS, Kang NW, Lee SB, Eickholz P, Pretzl B, Kim CK. Differences in subgingival microflora of Korean and German periodontal patients. Arch Oral Biol. 2009;54:223-9.
5. Renvert S, Roos-Jansåker AM, Lindahl C, Renvert H, Rutger PG. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin Oral Implants Res. 2007;18:509-16.
6. Ata-Ali J, Flichy-Fernández AJ, Alegre-Domingo T, Candel-Marti ME, Peñarrocha D, Balaguer-Martinez JF, et al. Analysis of the peri-implant microbiota in 90 dental implants and its relationship to crevicular fluid volume. Med Oral Patol Oral Cir Bucal. 2011;16:e944-7.
7. Lang NP, Bosshardt DD, Lulic M. Do mucositis lesions around implants differ from gingivitis lesions around teeth? J Clin Periodontol. 2011;11:182-7.
8. Hallström H, Persson GR, Lindgren S, Olofsson M, Renvert S. Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trial. J Clin Periodontol. 2012;39:574-81.
9. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res. 2002;13:349-58.
10. Botero JE, González AM, Mercado RA, Olave G, Contreras A. Subgingival microbiota in peri-implant mucosa lesions and adjacent teeth in partially edentulous patients. J Periodontol. 2005;76:1490-5.
11. Shibli JA, Melo L, Ferrari DS, Figueiredo LC, Faveri M, Feres M. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Implants Res. 2008;19:975-82.
12. Persson GR, Samuelsson E, Lindahl C, Renvert S. Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II Microbiological Results J Clin Periodontol. 2010;37:563-73.
13. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent Jr. RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134-44.
14. Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, Peñarrocha-Oltra D, Balaguer-Martinez JF, Peñarrocha DM. Peri-implantitis: associated microbiota and treatment. Med Oral Patol Oral Cir Bucal. 2011;16:e937-43.
15. Kocar M, Seme K, Hren NI. Characterization of the normal bacterial flora in periimplant sulci of partially and completely edentulous patients. Int J Oral Maxillofac Implants. 2010;25:690-8.
16. Petković AB, Matić SM, Stamatović NV, Vojvodić DV, Todorović TM, Lazić ZR, et al. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg. 2010;39:478-85.
17. Melo RF, Lopes BM, Shibli JA, Marcantonio Junior E, Marcantonio RA, Galli GM. Interleukin-1β and Interleukin-6 Expression and Gene Polymorphisms in Subjects with Peri-Implant Disease. Clin Implant Dent Relat Res. 2012;14:905-14.
18. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants. 2006;21:543-50.
19. Nowzari H, Yi K, Chee W, Rich SK. Immunology, microbiology, and virology following placement of NobelPerfect scalloped dental implants: analysis of a case series. Clin Implant Dent Relat Res. 2008;10:157-65.
20. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000. 1997;14:216-48.
21. Nares S. The genetic relationship to periodontal disease. Periodontol 2000. 2003;32:36-49.
22. Schwarz F, Sculean A, Rothamel D, Schwenzer K, Georg T, Becker J. Clinical evaluation of an Er: YAG laser for nonsurgical treatment of peri-implantitis: a pilot study. Clin Oral Implants Res. 2005;16:44-52.
23. Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res. 2008;10:166-73.
24. Duarte PM, de Mendonça AC, Máximo MB, Santos VR, Bastos MF, Nociti FH. Effect of anti-infective mechanical therapy on clinical parameters and cytokine levels in human peri-implant diseases. J Periodontol. 2009;80:234-43.
25. Mombelli A, Van Oosten MAC, Schürch E, Lang NP. The microbiota associated with succesful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987;2:145-51.
26. Giannopoulou C, Bernard JP, Buser D, Carrel A, Belser UC. Effect of intracrevicular restoration margins on peri-implant health: clinical, biochemical, and microbiologic findings around esthetic implants up to 9 years. Int J Oral Maxillofac Implants. 2003;18:173-81.
27. Lang NP, Berglundh T, Working Group 4 of Seventh European Workshop on Periodontology. Periimplant diseases: where are we now? Consensus of the Seventh European workshop on periodontology. J Clin Periodontol. 2011;11:178-81.
28. Luterbacher S, Mayfield L, Brägger U, Lang NP. Diagnostic characteristics of clinical and microbiological tests for monitoring periodontal and peri-implant mucosal tissue conditions during supportive periodontal therapy (SPT). Clin Oral Implants Res. 2000;11:521-9.
29. Kamma JJ, Baehni PC. Five-year maintenance follow-up of early-onset periodontitis patients. J Clin Periodontol. 2003;30:562-72.
30. Mombelli A, Brochut P, Plagnat D, Casagni F, Giannopoulou C. Enamel matrix proteins and systemic antibiotics as adjuncts to non-surgical periodontal treatment: clinical effects. J Clin Periodontol. 2005;32(3):225-30.
31. Lachmann S, Stehberger A, Axmann D, Weber H. The peri-implant health in patients attending an annual recall program. A clinical and microbiological study in 74 patients from the Tübingen Implant Registry. Clin Oral Implants Res. 2013;24:1300-9.
32. Heitz-Mayfield LJ, Lang NP. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000. 2000;53:167-81.
33. Ata-Ali J, Flichy-Fernandez AJ, Ata-Ali F, Penarrocha-Diago M, Penarrocha-Diago M. Clinical, microbiologic, and host response characteristics in patients with peri-implant mucositis. Int J Oral Maxillofac Implants. 2013;28:883-90.
34. Ata-Ali J, Ata-Ali F, Galindo-Moreno P. Treatment of periimplant mucositis: a systematic review of randomized controlled trials. Implant Dent. 2015;24:13-8. 10.1097/ID.0000000000000190.
35. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: a review of the literature. Clin Oral Implants Res. 2002;13:1-19.
36. Roos-Jansåker AM, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part I: implant loss and associations to various factors. J Clin Periodontol. 2006;33:283-9.
37. Roos-Jansåker AM, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part II: presence of peri-implant lesions. J Clin Periodontol. 2006;33:290-5.
38. Roos-Jansåker AM, Renvert H, Lindahl C, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part III: factors associated with peri-implant lesions. J Clin Periodontol. 2006;33:296-301.
39. Carcuac O, Jansson L. Peri-implantitis in a specialist clinic of periodontology. Clinical features and risk indicators. Swed Dent J. 2010;34:53-61.
40. Rinke S, Ohl S, Ziebolz D, Lange K, Eickholz P. Prevalence of periimplant disease in partially edentulous patients: a practice-based cross-sectional study. Clin Oral Implants Res. 2011;22:826-33.
41. Marrone A, Lasserre J, Bercy P, Brecx MC. Prevalence and risk factors for peri-implant disease in Belgian adults. Clin Oral Implants Res. 2013;24:934-40.
42. Laugisch O, Schacht M, Guentsch A, Kantyka T, Sroka A, Stennicke HR, et al. Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid. Mol Oral Microbiol. 2012;27:45-56.
43. Chen W, Kajiya M, Giro G, Ouhara K, Mackler HE, Mawardi H, et al. Bacteria-derived hydrogen sulfide promotes IL-8 production from epithelial cells. Biochem Biophys Res Commun. 2010;391:645-50.
44. Leonhardt A, Renvert S, Dahlén G. Microbial findings at failing implants. Clin Oral Implants Res. 1999;10:339-45.
45. De Boever AL, De Boever JA. Early colonization of non-submerged dental implants in patients with a history of advanced aggressive periodontitis. Clin Oral Implants Res. 2006;17:8-17.
46. Heuer W, Elter C, Demling A, Neumann A, Suerbaum S, Hannig M, et al. Analysis of early biofilm formation on oral implants in man. J Oral Rehabil. 2007;34:377-82.
47. Emrani J, Chee W, Slots J. Bacterial colonization of oral implants from non-dental sources. Clin Implant Dent Relat Res. 2009;11:106-12.
48. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003;74:391-401.
49. Jandinski JJ, Stashenko P, Feder LS, Leung CC, Peros WJ, Rynar JE, et al. Localization of interleukin-1 beta in human periodontal tissue. J Periodontol. 1991;62:36-43.
50. Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol. 1991;62:504-9.
51. Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res. 2002;13:470-6.
52. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants. 1996;11:794-9.
53. Plagnat D, Giannopoulou C, Carrel A, Bernard JP, Mombelli A, Belser UC. Elastase, alpha2-macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis. Clin Oral Implants Res. 2002;13:227-33.
54. Candel-Martí ME, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali J, Peñarrocha-Diago MA. Interleukins IL-6, IL-8, IL-10, IL-12 and periimplant disease. An update Med Oral Patol Oral Cir Bucal. 2011;16:e518-21.
55. Pigossi SC, Alvim-Pereira F, Montes CC, Finoti LS, Secolin R, Trevilatto PC, et al. Genetic association study between Interleukin 10 gene and dental implant loss. Arch Oral Biol. 2012;57:1256-63.
56. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992;175(3):671-82.
57. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, et al. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol. 1998;27:142-5.
58. Duarte PM, De Mendonça AC, Máximo MB, Santos VR, Bastos MF, Nociti Júnior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res. 2009;20:514-20.
59. Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants. 1998;13:689-96.
60. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res. 2002;13:637-43.
61. Havemose-Poulsen A, Sorensen L, Stoltz K, Bendtzen K, Holmstrup P. Cytokine profiles in peripheral blood and whole blood cultures associated with aggressive periodontitis, juvenile idiopathic arthritis and rheumatoid arthritis. J Periodontol. 2005;76:2276-85.
62. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-8.
63. Ejeil AL, Gaultier F, Igondio-Tchen S, Senni K, Pellat B, Godeau G, et al. Are cytokines linked to collagen breakdown during periodontal disease progression? J Periodontol. 2003;74:196-201.
64. Yamazaki K, Nakajima N. Antigen specificity and T cell clonality in periodontal disease. Periodontol 2000. 2004;35:75-100.
65. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84:1045-9.
66. Deo V, Bhongade ML. Pathogenesis of periodontitis: role of cytokines in host response. Dent Today. 2010;29:60-9.
67. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol. 2003;74:188-95.
68. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol. 2000;71:1535-45.
69. Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol. 2001;72:590-7.